Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination

Vaccine

Volumn 30, Issue 6, 2012, Pages 1191-1197

  Naito, Seishiro ^a   Ito, Yukako ^b   Kiyohara, Tomoko ^a   Kataoka, Michiyo ^a   Ochiai, Masaki ^a   Takada, Kanji ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Delivery system; Intradermal injection; Skin immunization

Indexed keywords

CHONDROITIN SULFATE; OVALBUMIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN LOADED DISSOLVING MICRONEEDLE ARRAY PATCH; ANTIGEN SPECIFICITY; ARTICLE; DENDRITIC CELL; DOSE RESPONSE; DRUG DELIVERY SYSTEM; FEMALE; IMMUNIZATION; IMMUNOCOMPETENT CELL; MOUSE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; TRANSDERMAL PATCH; VACCINATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EQUIPMENT AND SUPPLIES; FEMALE; MICE; MICE, INBRED BALB C; OVALBUMIN; VACCINATION;

EID: 84856325900     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.111     Document Type: Article

References (38)

1. Nestle F.O., Meglio P.D., Qin J.Z., Nickoloff B.J. Skin immune sentinels in health and disease. Nat Rev Immunol 2009, 9:679-691.
2. Heath W.R., Carbone F.R. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 2009, 10(12):1237-1244.
3. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Hoecke C.V., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004, 351:2286-2294.
4. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004, 351:2295-2301.
5. Hickling J., Jones R. Intradermal delivery of vaccines: a review of the literature and the potential for development for use in low- and middle-income countries 2009, Program for Appropriate Technology in Health, Seattle.
6. Launay O., Durier C., Desaint C., Silbermann B., Jackson A., Pialoux G., et al. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. PLoS One 2007, 2(8):e725.
7. Quan F.S., Kim Y.C., Vunnava A., Yoo D.G., Song J.M., Prausnitz M.R., et al. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol 2010, 84(15):7760-7769.
8. ® microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res 2002, 19(1):63-70.
9. McAllister D.V., Wang P.M., Davis S.P., Park J.H., Canatella P.J., Allen M.G., et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA 2003, 100(24):13755-13760.
10. Laurent P.E., Bonnet S., Alchas P., Regolini P., Mikszta J.A., Pettis R., et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007, 25:8833-8842.
11. Van Damme P., Oosterhuis-Kafeja F., Van der W.M., Almagor Y., Sharon O., Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 2009, 27:454-459.
12. Sullivan S.P., Koutsonanos D.G., Martin N.D.P., Lee J.W., Zarnitsyn V., Choi S.O., et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med 2010, 16(8):915-920.
13. Ito Y., Yamazaki N., Sugioka N., Takada K. Self-dissolving micropile array chips for percutaneous administration of insulin. J Mater Sci Mater Med 2009, 21:835-841.
14. Ito Y., Maeda T., Fukushima K., Sugioka N., Takada K. Self-dissolving microarray chip as percutaneous delivery system of protein drug. Biol Pharm Bull 2010, 33:683-690.
15. Ito Y., Hagiwara E., Saeki A., Sugioka N., Takada K. Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharmaceut Sci 2006, 29:82-88.
16. Ito Y., Yoshimitsu I., Shiroyama N., Sugioka N., Takada K. Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J Drug Target 2006, 14:255-262.
17. Ito Y., Murakami T., Maeda N., Sugioka N., Takada K. Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats. Int J Pharmaceut 2008, 349:124-129.
18. Ito Y., Saeki K., Shiroyama N., Sugioka N., Takada K. Percutaneous absorption of interferon-α by self-dissolving micropiles. J Drug Target 2008, 16:243-249.
19. Ito Y., Ohashi Y., Shiroyama K., Sugioka N., Takada K. Self-dissolving micropiles for percutaneous absorption of human growth hormone in rats. Biol Pharm Bull 2008, 31:1631-1633.
20. Ito Y., Ise A., Sugioka N., Takada K. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin. Drug Dev Ind Pharm 2010, 36:845-851.
21. Naito S., Maeyama J., Mizukami T., Takahashi M., Hamaguchi I., Yamaguchi K. Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant. Vaccine 2007, 25:8762-8770.
22. Glenn G.M., Rao M., Matyas G.R., Alving C.R. Skin immunization made possible by cholera toxin. Nature 1998, 391:851.
23. Godefroy S., Goestch L., Plotnicky-Gilquin H., Nguyen T.N., Schmitt D., Staquet M.J., et al. Immunization onto shaved skin with bacterial enterotoxin adjuvant protects mice against Respiratory Syncytial Virus (RSV). Vaccine 2003, 21:1665-1671.
24. Berry L.J., Hickey D.K., Skelding K.A., Bao S., Rendina A.M., Hansbro P.M., et al. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect Immun 2004, 72(2):1019-1028.
25. Partidos C.D., Beignon A.S., Briand J.P., Muller S. Modulation of immune responses with transcutaneously deliverable adjuvants. Vaccine 2004, 22:2385-2390.
26. Glenn G.M., Scharton-Kersten T., Vassell R., Matyas G.R., Alving C.R. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect Immun 1999, 67(3):1100-1106.
27. Glenn G.M., Taylor D.N., Li X., Frankel S., Montemarano A., Alving C.R. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 2000, 6(12):1403-1406.
28. Rechtsteiner G., Warger T., Osterloh P., Schild H., Radsak M.P. Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod. J Immunol 2005, 174(5):2476-2480.
29. Tierney R., Beignon A.S., Rappuoli R., Muller S., Sesardic D., Partidos C.D. Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody. J Infect Dis 2003, 188(5):753-758.
30. Godefroy S., Peyre M., Garcia N., Muller S., Seardic D., Partidos C.D. Effect of skin barrier disruption on immune responses to topically applied cross-reacting material, CRM(197), of diphtheria toxin. Infect Immun 2005, 73(8):4803-4809.
31. Takada K. Microfabrication derived DDS: from batch to individual production. Drug Discov Ther 2008, 2(3):140-155.
32. Arora A., Prausnitz M.R., Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008, 364:227-236.
33. Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O'Dell J.R., Hooper M.M., et al. Glucosamine: chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006, 354(8):795-808.
34. Hochberg M.C., Zhan M., Langenberg P. The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate. Curr Med Res Opin 2008, September 29 [Epub ahead of print].
35. Miyano T., Tobinaga Y., Kanno T., Matsuzaki Y., Takeda H., Wakui M., et al. Sugar micro needles as transdermic drug delivery system. Biomed Microdevices 2005, 7:185-188.
36. Park J.H., Allen M.G., Prausnitz M.R. Polymer microneedles for controlled-release drug delivery. Pharm Res 2006, 23(5):1008-1019.
37. Lee J.W., Park J.H., Prausnitz M.R. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008, 29:2113-2124.
38. Ito Y., Yamazaki T., Sugioka N., Takada K. Self-dissolving micropile array chips for percutaneous administration of insulin. J Mater Sci Mater Med 2010, 21:835-841.